50 related articles for article (PubMed ID: 31495136)
1. Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction.
Li J; Lu A; Gao Y; Wan Y; Wang J; Zhang J; Hu T; Wu P; Chen X; Zou Y; Chen Y; Zhang L; Guo Y; Yang W; Li C; Zhang Y; Zhu X
Haematologica; 2024 May; ():. PubMed ID: 38695139
[TBL] [Abstract][Full Text] [Related]
2. [A correlation study between the minimal residual disease detection using multiparameter flow cytometry and prognosis of childhood acute B lymphoblastic leukemia].
Feng J; Chen XJ; Liu XM; Zou Y; Guo Y; Yang WY; Chen YM; Zhang L; Wang SC; Ruan M; Liu F; Liu TF; Qi BQ; Zhu XF; Wang HJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):678-680. PubMed ID: 31495136
[No Abstract] [Full Text] [Related]
3. A concise review of flow cytometric methods for minimal residual disease assessment in childhood B-cell precursor acute lymphoblastic leukemia.
Baldzhieva A; Burnusuzov HA; Murdjeva MA; Dimcheva TD; Taskov HB
Folia Med (Plovdiv); 2023 Jun; 65(3):355-361. PubMed ID: 38351809
[TBL] [Abstract][Full Text] [Related]
4. Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia.
Choi JK; Mead PE
Clin Lab Med; 2021 Sep; 41(3):485-495. PubMed ID: 34304777
[TBL] [Abstract][Full Text] [Related]
5. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
Fossat C; Roussel M; Arnoux I; Asnafi V; Brouzes C; Garnache-Ottou F; Jacob MC; Kuhlein E; Macintyre-Davi E; Plesa A; Robillard N; Tkaczuk J; Ifrah N; Dombret H; Béné MC; Baruchel A; Garand R;
Cytometry B Clin Cytom; 2015 Jan; 88(1):21-9. PubMed ID: 25363877
[TBL] [Abstract][Full Text] [Related]
6. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.
Gaipa G; Basso G; Biondi A; Campana D
Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107
[TBL] [Abstract][Full Text] [Related]
7. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
8. Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selection.
Theunissen PMJ; de Bie M; van Zessen D; de Haas V; Stubbs AP; van der Velden VHJ
Leuk Res; 2019 Jan; 76():98-104. PubMed ID: 30389174
[TBL] [Abstract][Full Text] [Related]
9. Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: The first nation-wide prospective multicenter study in China.
Cui L; Li ZG; Chai YH; Yu J; Gao J; Zhu XF; Jin RM; Shi XD; Zhang LP; Gao YJ; Zhang RD; Zheng HY; Hu SY; Cui YH; Zhu YP; Zou Y; Ng MHL; Xiao Y; Li JH; Zhang YH; He HL; Xian Y; Wang TY; Li CK; Wu MY;
Am J Hematol; 2018 Jul; 93(7):913-920. PubMed ID: 29675840
[TBL] [Abstract][Full Text] [Related]
10. [Expert consensus on minimal residual disease detection of acute leukemia and plasma cell neoplasms by multi-parameter flow cytometry].
Chinese Society of Immunology, Clinical Flow Cytometry Group
Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1001-1011. PubMed ID: 29365391
[No Abstract] [Full Text] [Related]
11. Acute lymphoblastic leukemia: a comprehensive review and 2017 update.
Terwilliger T; Abdul-Hay M
Blood Cancer J; 2017 Jun; 7(6):e577. PubMed ID: 28665419
[TBL] [Abstract][Full Text] [Related]
12. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.
Berry DA; Zhou S; Higley H; Mukundan L; Fu S; Reaman GH; Wood BL; Kelloff GJ; Jessup JM; Radich JP
JAMA Oncol; 2017 Jul; 3(7):e170580. PubMed ID: 28494052
[TBL] [Abstract][Full Text] [Related]
13. Monitoring minimal residual disease in acute leukemia: Technical challenges and interpretive complexities.
Chen X; Wood BL
Blood Rev; 2017 Mar; 31(2):63-75. PubMed ID: 27742133
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
